![Alexander Sparre-Ulrich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexander Sparre-Ulrich
Director Ejecutivo en Antag Therapeutics ApS .
Perfil
Alexander Sparre-Ulrich is the founder and current Chief Executive Officer of Antag Therapeutics ApS, which is founded in 2017.
Cargos activos de Alexander Sparre-Ulrich
Empresas | Cargo | Inicio |
---|---|---|
Antag Therapeutics ApS
![]() Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Director Ejecutivo | 01/01/2017 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Antag Therapeutics ApS
![]() Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Alexander Sparre-Ulrich